CLEVELAND, OHIO, USA & OSAKA, JAPAN – September 25, 2014
BioMotiv, the therapeutic accelerator company associated with The Harrington Project for Discovery & Development, and Takeda Pharmaceutical Company jointly announced today that Takeda has made a strategic investment in BioMotiv and formed a partnership that will leverage the strengths of both organizations to identify and develop pioneering medical innovations.

Click here to read more

Click here to read in Japanese